Bupivacaine Injection, Suspension, Liposomal
Product Images NDC 57884-3252

This appears to be a graph or table showing the effect of placebo and bupivacaine at different time intervals (0, 2, 24, 48, and 72 hours). The text "PI" is likely a heading or label. The graph/table may be related to the assessment of pain relief or anesthetic effects of bupivacaine compared to a placebo over time.*

This is a description of a medication called Bupivacaine Liposome, an injectable suspension for infiltration and interscalene brachial plexus nerve block. It is a sterile solution that should be stored in a refrigerator between 2°C to 8°C (36°F to 46°F). The medication comes in a 10 mL single-dose vial and the usual dosage should be referenced from the package insert. Instructions are given on how to use or discard any unused portion of the product. The manufacturer is Jiangsu Hengrui Pharmaceuticals Co., Ltd., China, and it is distributed by Venus Pharmaceutical Laboratories, Inc., USA. The medication should not be frozen and should be used within 30 days after removing it from the refrigerator or before the labeled expiration date, whichever comes first.*

This is a description of an injectable suspension of Levobupivacaine Liposome, a medication used for infiltration and interscalene brachial plexus nerve block. The suspension contains 1.3% Levobupivacaine, with a concentration of 266 mg/20 mL (13.3 mg/mL). It is provided in a sterile 20 mL single-dose vial that should not be frozen but refrigerated at 2°C to 8°C (36°F to 46°F). The product should not be filtered, and any unused portion should be discarded. The usual dosage should be referred to the package insert. This medication is manufactured by Jiangsu Hengrui Pharmaceuticals Co., Ltd., China, and distributed by eVenus Pharmaceutical Laboratories, Inc., USA. It is advised to use or discard the product within 30 days after removal from the refrigerator or before the labeled expiration date.*